293b cpd has been researched along with nicorandil in 2 studies
| Studies (293b cpd) | Trials (293b cpd) | Recent Studies (post-2010) (293b cpd) | Studies (nicorandil) | Trials (nicorandil) | Recent Studies (post-2010) (nicorandil) |
|---|---|---|---|---|---|
| 100 | 0 | 16 | 1,487 | 207 | 428 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antzelevitch, C; Shimizu, W | 1 |
| Li, C; Liu, K; Liu, Y; Shi, G; Wang, H; Yang, Z | 1 |
2 other study(ies) available for 293b cpd and nicorandil
| Article | Year |
|---|---|
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chromans; Cnidarian Venoms; Dogs; Electrocardiography; Electrophysiology; Heart; Isoproterenol; Long QT Syndrome; Nicorandil; Potassium Channels; Reaction Time; Sotalol; Sulfonamides; Torsades de Pointes | 2000 |
Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model.
Topics: Action Potentials; Animals; Chromans; Disease Models, Animal; Electrocardiography; Guinea Pigs; In Vitro Techniques; Long QT Syndrome; Nicorandil; Potassium Channel Blockers; Sulfonamides; Vasodilator Agents | 2004 |